EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME

<p>Dual antiplatelet therapy, including clopidogrel and aspirin, in a significant share of patients after acute coronary syndrome (ACS) is characterized by high level of platelet reactivity, which is associated with an increased incidence of cardiovascular events. Perhaps it will make reasonable the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	A. V. Rudakova, N. V. Lomakin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Столичная издательская компания 2015-09-01
coleção:	Рациональная фармакотерапия в кардиологии
Assuntos:	острый коронарный синдром антитромбоцитарная терапия анализ реактивности тромбоцитов анализ эффективности затрат
Acesso em linha:	http://www.rpcardio.ru/jour/article/view/136
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!